Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMN as an anti-ageing supplement in adults aged 40-65
NCT04823260Completed
- Sponsor
- Abinopharm
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicotinamide mononucleotide in aging, sponsored by Abinopharm. Started May 2021; status: completed.
02
Drugs
nicotinamide mononucleotide
03
Conditions
aging
Beyond the preview
Go deeper on NCT04823260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04823260.